BRIDGES INVESTMENT MANAGEMENT INC has added 102,014 shares of $CSL to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CSL.
CARLISLES Hedge Fund Activity
We have seen 357 institutional investors add shares of CARLISLES stock to their portfolio, and 359 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF NEW YORK MELLON CORP added 558,710 shares (+113.9%) to their portfolio in Q3 2025, for an estimated $183,793,241
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC removed 510,817 shares (-39.9%) from their portfolio in Q3 2025, for an estimated $168,038,360
- SANDS CAPITAL MANAGEMENT, LLC added 426,360 shares (+inf%) to their portfolio in Q2 2025, for an estimated $159,202,824
- MORGAN STANLEY added 403,020 shares (+13.5%) to their portfolio in Q2 2025, for an estimated $150,487,668
- JPMORGAN CHASE & CO added 358,241 shares (+33.2%) to their portfolio in Q2 2025, for an estimated $133,767,189
- NORGES BANK removed 219,100 shares (-38.8%) from their portfolio in Q2 2025, for an estimated $81,811,940
- LEITH WHEELER INVESTMENT COUNSEL LTD. added 214,226 shares (+755.3%) to their portfolio in Q2 2025, for an estimated $79,991,988
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CARLISLES Congressional Stock Trading
Members of Congress have traded $CSL stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CSL stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CARLISLES Analyst Ratings
Wall Street analysts have issued reports on $CSL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/30/2025
- Baird issued a "Outperform" rating on 10/13/2025
To track analyst ratings and price targets for CARLISLES, check out Quiver Quantitative's $CSL forecast page.
CARLISLES Price Targets
Multiple analysts have issued price targets for $CSL recently. We have seen 6 analysts offer price targets for $CSL in the last 6 months, with a median target of $390.0.
Here are some recent targets:
- Tomohiko Sano from JP Morgan set a target price of $400.0 on 10/30/2025
- Keith Hughes from Truist Securities set a target price of $340.0 on 10/30/2025
- Bryan Blair from Oppenheimer set a target price of $415.0 on 10/20/2025
- Timothy Wojs from Baird set a target price of $385.0 on 10/13/2025
- Susan Maklari from Goldman Sachs set a target price of $385.0 on 10/13/2025
- Garik Shmois from Loop Capital set a target price of $395.0 on 07/31/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $CSL ticker page for more data.
